Chinese regulators have told domestic investment banks to keep IPO pricing conservative and block low-quality issuers, aiming to protect retail confidence after a year in which mainland listings raised over $28 billion and posted a median first-day return of 173%.
Beijing has moved to slow the money machine behind China's listing boom, telling domestic investment banks to price new offerings cheaply and keep weaker companies out of the queue. The guidance, reported by the Financial Times citing people familiar with the discussions, was delivered in meetings with senior bankers and reflects the government's push to rebuild retail confidence in the equity market.
Regulators "reiterated their preference for maintaining a conservative IPO pricing approach," according to the report, which described the meetings as involving senior domestic investment bankers. The FT said officials also signaled they want to avoid triggering a new wave of listings, particularly from companies not regarded as representatives of the "national team."
The instruction lands on top of a market that has already recovered hard. HSBC analysts calculate that more than 100 companies have listed on the mainland this year, raising over $28 billion — nearly 50% more than the whole of last year. The median first-day return for Chinese IPOs in 2025 has reached 173%, a figure that explains why regulators are now focused on pricing rather than volume.
Two recent debuts illustrate the dynamic. CXMT (688825.SH) and Yushu Technology (688836.SH) both priced below levels typical of Western exchanges and drew heavy investor demand; each surged more than 400% on its first trading day. That pattern — a low offer price converting into a fourfold open — is precisely what a conservative-pricing policy is designed to moderate, because it transfers value from issuers to the secondary market and invites speculative churn.
The policy logic runs through retail confidence. A market where new listings quadruple on day one looks like a lottery; a market where they drift below their offer price looks broken. Beijing has spent the past two years trying to engineer the middle ground, and the current guidance extends that effort from the supply side — who gets to list — to the price side — at what level they list.
For the exchanges and underwriters, the read-through is mixed. A slower, more selective pipeline trims fee income for the securities firms that lead mainland offerings, but it also protects the aftermarket performance that keeps retail money engaged. Hong Kong Exchanges and Clearing (00388.HK) sits adjacent to the story: Goldman Sachs cut its target price on HKEX to HK$532 while maintaining a Buy rating, a reminder that the mainland's listing cadence feeds directly into the Hong Kong venue's franchise.
The historical anchor is the 2023-2024 stretch, when regulators slowed approvals sharply to drain a backlog of weak issuers and stabilize the Shanghai and Shenzhen benchmarks. That pause worked on supply but starved the market of new paper; the current approach tries to keep the pipeline open while constraining price. Whether the two goals can coexist will show up in the first-day returns of the next batch of listings — if the median drifts down from 173% toward the historical norm, the guidance is biting.
What happens next depends on how the guidance is enforced. If banks read it as a soft preference, pricing stays aggressive and the first-day pop persists. If it hardens into an approval condition, expect smaller deal sizes, lower offer prices, and a visible cooling in debut performance — with the knock-on effect of less speculative turnover in the A-share market and a more measured flow of new listings into Hong Kong.
This article is for informational purposes only and does not constitute investment advice.
